Gautam Adani’s Adani Enterprises Ltd. plans a $1.3 billion share sale via a qualified institutional placement starting as early as Oct. 7. The move follows a short-seller’s 2023 allegations of fraud, which led to a significant stock drop. The share issue aims to signal investor confidence and revive expansion efforts.
Pharma stocks rally up to 4%, but will Trump order really have minimal impact?
The Nifty Pharma index gained around 2% on Tuesday, defying the broader market trend, as the Nifty slipped nearly 0.5% amid profit-booking following Monday’s sharp
May 13, 2025